IP Library Granted Patent US 8,841,100
Granted Patent B2
US 8,841,100 · App. 13/029,001 · Granted Sep 23, 2014

Use of methylsulfonylmethane (MSM) to modulate microbial activity

Inventors: Rodney L. Benjamin (Camas, WA); Jeffrey Varelman (Moyie Springs, ID); Anthony L. Keller (Ashland, OR)
Assignee: Biogenic Innovations, LLC
A61K31/10A61K31/431A61K31/437A61K9/0014A61K31/43A61K45/06C12P7/56C12P7/06C12N1/20Y02E50/17A01N41/10Y02E50/343C12N1/18C12N1/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,841,100
App. No.
13/029,001
Granted
Sep 23, 2014
Kind
B2
Abstract

Disclosed herein are methods of use of methylsulfonylmethane (MSM) to modulate microbial activity, such as to enhance or inhibit the activity of microorganisms. In one example, MSM (such as about 0.5% to 5% MSM) is used to enhance fermentation efficiency, such as to enhance fermentation efficiency associated with the production of beer, cider, wine, a biofuel, dairy product or any combination thereof. Also disclosed are in vitro methods for enhancing the growth of one or more probiotic microorganisms and methods of enhancing growth of a microorganism in a diagnostic test sample. Methods of inhibiting microbial activity are also disclosed. In one particular example, a method of inhibiting microbial activity includes selecting a medium that is susceptible to H1N1 influenza contamination; and contacting the medium with MSM at a concentration of about 10% to about 16% of weight by volume, thereby inhibiting H1N1 influenza microbial activity.

Claims (25)

1. An in vitro method of enhancing fermentation efficiency of a eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof, the method comprising:

contacting, in vitro, methylsulfonylmethane (MSM), medium, and a eukaryotic microorganism capable of fermentation, wherein the MSM is provided at a concentration of 0.02%, 0.03%, 0.04%, 0.06%, 0.07%, 0.08%, 0.09%, 0.2%, 0.25%, or 0.3% by weight of the medium, wherein the MSM increases the fermentation efficiency of the eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof as compared to the fermentation efficiency of the eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof in the absence of MSM.

2. The in vitro method of claim 1 , wherein the eukaryotic microorganism is yeast and the method of enhancing fermentation is for the production of beer.

3. The in vitro method of claim 1 , wherein the eukaryotic microorganism is algae and the method of enhancing fermentation is for the production of biofuel.

4. The method of claim 1 , wherein the concentration of MSM is 0.2% by weight of the medium.

5. An in vitro method of enhancing fermentation efficiency of a eukaryotic microorganism, the method comprising:

contacting, in vitro, methylsulfonylmethane (MSM), medium, and a eukaryotic microorganism capable of fermentation, wherein the MSM is provided at a concentration of 0.02%, 0.03%, 0.04%, 0.06%, 0.07%, 0.08%, 0.09%, 0.2%, 0.25%, or 0.3% by weight of the medium, wherein the MSM increases the fermentation efficiency of the eukaryotic microorganism by increasing production of ethanol, methanol or a combination thereof by at least 50% as compared to production of ethanol, methanol or a combination of thereof in the absence of MSM.

6. The in vitro method of claim 5 , wherein the eukaryotic microorganism is yeast and the method of enhancing fermentation is for the production of beer.

7. The in vitro method of claim 5 , wherein the eukaryotic microorganism is algae and the method of enhancing fermentation is for the production of biofuel.

8. The in vitro method of claim 5 , wherein the MSM is provided at a concentration of 0.2% by weight of the medium.

9. The in vitro method of claim 5 , wherein the MSM is provided at a concentration of 0.25% by weight of the medium.

10. An in vitro method of enhancing fermentation efficiency of a eukaryotic microorganism, the method comprising:

contacting, in vitro, methylsulfonylmethane (MSM), medium, and a eukaryotic microorganism capable of fermentation, wherein the MSM is provided at a concentration of 0.02%, 0.03%, 0.04%, 0.06%, 0.07%, 0.08%, 0.09%, 0.2%, 0.25%, or 0.3% by weight of the medium, wherein the MSM increases the fermentation efficiency by increasing carbon dioxide production by the eukaryotic microorganism by at least 50% in the presence of MSM as compared to carbon dioxide production in the absence of MSM, the eukaryotic microorganism is yeast and the method of enhancing fermentation is for the production of bread.

11. The in vitro method of claim 10 , wherein the MSM is provided at a concentration of 0.2% by weight of the medium.

12. The in vitro method of claim 10 , wherein the MSM is provided at a concentration of 0.25% by weight of the medium.

13. The in vitro method of claim 10 , wherein the MSM is provided at a concentration of 0.3% by weight of the medium.

14. An in vitro method of enhancing fermentation efficiency of a eukaryotic microorganism, the method comprising:

contacting, in vitro, methylsulfonylmethane (MSM), medium, and a eukaryotic microorganism capable of fermentation, wherein the MSM is provided at a concentration of 0.02%, 0.03%, 0.04%, 0.06%, 0.07%, 0.08%, 0.09%, 0.2%, 0.25%, or 0.3% by weight of the medium, wherein the MSM increases the fermentation efficiency by increasing lactic acid production by the eukaryotic microorganism by at least 50% in the presence of MSM as compared to lactic acid production in the absence of MSM and the method of enhancing fermentation is for the production of a dairy product.

15. The in vitro method of claim 14 , wherein the MSM is provided at a concentration of 0.2% by weight of the medium.

16. The in vitro method of claim 14 , wherein the MSM is provided at a concentration of 0.25% by weight of the medium.

17. The in vitro method of claim 14 , wherein the MSM is provided at a concentration of 0.3% by weight of the medium.

18. An in vitro method of enhancing fermentation efficiency of a eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof, the method comprising:

contacting, in vitro, methylsulfonylmethane (MSM), medium, and a eukaryotic microorganism capable of fermentation, wherein the MSM is provided at a concentration of 0.25% by weight of the medium, wherein the MSM increases the fermentation efficiency of the eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof as compared to the fermentation efficiency of the eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof in the absence of MSM.

19. An in vitro method of enhancing fermentation efficiency of a eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof, the method comprising:

contacting, in vitro, methylsulfonylmethane (MSM), medium, and a eukaryotic microorganism capable of fermentation, wherein the MSM is provided at a concentration of 0.3% by weight of the medium, wherein the MSM increases the fermentation efficiency of the eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof as compared to the fermentation efficiency of the eukaryotic microorganism for the production of beer, cider, wine, a biofuel, bread, dairy product or any combination thereof in the absence of MSM.

Assignments (4)
SECURITY INTEREST Recorded Jul 24, 2026
From: ALBION LABORATORIES, INC.; BALCHEM CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075393/0698 →
MERGER Recorded Jun 11, 2024
From: CARDINAL ASSOCIATES, INC.
To: ALBION LABORATORIES, INC.
Reel/Frame 067695/0404 →
ASSET ASSIGNMENT AGREEMENT Recorded Jun 11, 2024
From: BIOGENIC INNOVATIONS, LLC
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 067698/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2011
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 025983/0906 →
Continuity (6)
Continuation PCTUS2010054845 · Oct 29, 2010
Provisional Application 61294437 · Jan 12, 2010
Provisional Application 61259098 · Nov 6, 2009
Provisional Application 61257751 · Nov 3, 2009
Provisional Application 61256935 · Oct 30, 2009
Related Publication 20110136210A1 · Jun 9, 2011